Notch signaling dysregulation plays an important role in altering cancer cell behaviors; however, its role in oral squamous cell carcinoma (OSCC) remains controversial. This study aimed to investigate the role of Notch signaling related genes in human OSCC using a meta-analysis of Gene Expression Omnibus database (GEO-publicly available gene expression microarray data) and to examine the role of Notch signaling in OSCC behaviors. The meta-analysis included 13 GEO datasets and was performed by combining effect sizes in a random effect model. The results demonstrated that in OSCC dysregulated genes participated in the metabolic process and protein binding as determined by gene ontology analysis. Enriched pathway analysis demonstrated the majority of the dysregulated genes were involved in pathway categories as follow; pathway in cancers, small cell lung cancer, extracellular matrix-receptor interaction, focal adhesion, and cell cycle progression. Interestingly, the enriched pathway analysis also demonstrated that OSCC samples exhibited an upregulation of genes in Notch signaling pathway, namely JAG1, JAG2, ADAM17,  NCSTN, PSEN1, NCOR2, NUMB, DVL3, HDAC1,  and HDAC2. Furthermore, Notch signaling inhibition by a γ-secretase inhibitor significantly decreased OSCC cell proliferation in vitro, corresponding with a decrease in C-FOS mRNA expression. The study demonstrated that Notch signaling is dysregulated in human OSCC and plays a role in cell proliferation. (J Oral Sci 58, 283-294, 2016)
Introduction
Alteration of Notch signaling plays a role in development and progression of cancer in various human tissues. Dysregulation of Notch receptors, ligands, or target genes is noted in various cancer cells (1, 2) . Notch signaling inhibition has been demonstrated to attenuate cancer cell proliferation/cell cycle progression, to decrease cancer cell viability, and to increase cell apoptosis in various types of cancer (1, (3) (4) (5) (6) . Furthermore, Notch signaling inhibition is proposed as an alternative adjuvant therapy for radiotherapy and chemotherapy (7, 8) . On the contrary, Notch signaling also has anti-cancer role; upregulation of NOTCH1 decreases neuroendocrine tumor growth (9) . Furthermore, Notch signaling inactivation is associated with the aggressive progression of urothelial and hepatocellular carcinoma (10, 11) . Thus, Notch signaling is involved in the pathogenesis of several cancer types but has different effects in different tissue types.
Oral squamous cell carcinoma (OSCC) is a common type of cancer. The most commonly affected site is the tongue, followed by the lips, oral mucosa, and gingiva (12) . Role of Notch signaling in OSCC remains controversial. It has been shown that OSCC expressed JAG1, a canonical Notch ligand (13) . Downregulation of NOTCH1 in OSCC results in a decrease in TNF-alphamediated cancer stem cell induction (14) . Furthermore, NOTCH1 protein expression in cancer is associated with Journal of Oral Science, Vol. 58, No. 2, 283-294, 2016 Original Expression and influence of Notch signaling in oral squamous cell carcinoma lymph node metastasis and cancer invasion (15) . Using bioinformatic evaluation, the NOTCH1 protein is ranked 4th on the list of OSCC-related proteins, implying its crucial role in the development of OSCC (16) . On the other hand, Notch may also attenuate development of oral cancer. Although this hypothesis was supported by evidence that demonstrated the presence of NOTCH1 mutation in OSCC patients (17, 18) ; the role of Notch signaling in OSCC is yet to be clarified. The Gene Expression Omnibus (GEO) database has grown tremendously in recent years (19) . It is extremely useful for data mining to identify and evaluate new hypotheses. Various publications using such databases have been reported to identify novel pathway(s) or molecule(s) as new targets for treatment and prediction of cancer (20) (21) (22) . One limitation of microarray database is that the use of cross platform analysis is restricted. Recently, Integrative Meta-analysis of Expression Data (INMEX), a web-based analysis, was introduced as an alternative analytical tool for horizontal and vertical data integration (23) . Combining the information from high number of datasets could result in the novel identification of dysregulation pathway in human OSCC.
Therefore, the present study aimed to investigate Notch signaling dysregulation related genes in human OSCC using a meta-analysis of GEO dataset. In addition, the influence of Notch signaling in OSCC proliferation and migration was examined.
Materials and Methods

Microarray dataset selection and processing
Microarray dataset repository in GEO (19) was searched (database until September 2014) using the following keywords: "oral cancer" or "oral squamous cell carcinoma". The databases were further evaluated based on the following inclusion criteria: 1) study investigating gene expression in human tissue biopsy; 2) study with samples containing normal oral tissue control and cancer tissues; and 3) study with each group containing more than 3 samples in the dataset. Expression datasets of human cell line were excluded in the study. The included GEO datasets (GSE) are shown in Table 1 (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) .
Series matrix file of each including datasets was downloaded. Probe ID of each platform was converted into an Entrez Gene ID. Probe IDs that did not match or had multiple matches with Entrez Gene IDs were excluded from the analysis. GSE samples that did not show cancerous changes (dysplasia) or presented carcinoma of the oral cavity (oropharynx and head and neck) were also excluded.
Meta-analysis procedure
Meta-analysis was performed using an online program called INMEX (23) . The processed datasets were uploaded. Intensity values were log-transformed, and quantile normalization was applied. Because of heterogeneities among different studies, the meta-analysis was performed by combining effect sizes in a random effect model. The significance level was set at P < 0.05.
Bioinformatics analysis
Differentially expressed genes were further analyzed for gene ontology (GO) classification and enriched pathway (KEGG pathway) using INMEX and WebGestalt (36, 37) . Pathway analysis by INMEX was performed using hypergeometric enrichment analysis and degree centrality topology analysis methods, with a threshold of P < 0.05. For WebGestalt, KEGG and GO enrichment analysis were applied using hypergeometric methods containing at least 2 differentially expressed genes with significance level set at P < 0.05.
Cell culture
Human OSCC cell lines (HSC-4 and HSC-5) were kindly provided by Professor Teuro Amagasa (Tokyo Medical and Dental University, Japan). The experimental plan was approved by the Human Ethics Committee, Faculty of Dentistry, Chulalongkorn University (081/2015, Study code: HREC-DCU 2015-076). HSC-4 was a metastatic phenotype of human OSCC, and HSC-5 was established from a primary tumor in human OSCC. Cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2 mM L-glutamine, 100 unit/mL penicillin, 100 μg/mL streptomycin, and 250 ng/mL amphotericin B at 37°C in a humidified 5% carbon dioxide atmosphere. All cell culture reagents were purchased from Gibco BRL (Carlsbad, CA, USA). For Notch signaling inhibition, a γ-secretase inhibitor (DAPT; Sigma-Aldirch Chemical, St. Louis, MO, USA) was added in the culture medium (treatment group); dimethyl sulfoxide in the same concentration was added as a vehicle control.
MTT assay
Cell viability and proliferation were determined using MTT assay. Cells were seeded on 24-well plates at a density of 12,500 cells/well. At day 1 and 3, cells were treated with 1 mg/mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solution (USB Corporation, Cleveland, OH, USA) for 10 min at 37°C. Formazan crystals were dissolved using dimethylsulfoxide and glycine buffer. Optical density of the solution was determined using a microplate reader at 540 nm.
Polymerase chain reaction
RNA was extracted using Isol-RNA Lysis reagent (5Prime, Gaitherburg, MD, USA) and was further converted to cDNA using a reverse transcriptase kit (Promega, Madison, WI, USA). Polymerase chain reaction was performed using FastStart Essential DNA Green Master (Roche Applied Science, Indianapolis, IN, USA) in a Lightcycler Nano Real-Time PCR machine (Roche Applied Science). The expression values were normalized to 18S expression and then normalized to the control results. The primer sequences are shown in Table 2 .
Wound healing assay
Cells were seeded in 35-mm tissue culture plates. Sterile blue pipette tip was used to scratch the monolayer of cell culture. Culture medium was changed to remove detached cells. Furthermore, cells were maintained in normal growth medium with or without DAPT supplementation for 24 h. At 0 and 24 h, images of the wound were captured at the same location using mark on phase contrast microscope to directly compare gap of the wound. Relative migration ratio was calculated based on previous study (38) .
Statistical analysis
The data were presented as mean +/-standard deviation. The Mann-Whitney U test was employed to compare the statistical differences between two-group. Kruskal-Wallis analysis followed by pairwise comparison was employed for three more group comparisons. Statistical analysis was performed using IBM SPSS Statistics for Mac, Version 22 (Armonk, NY, USA). Differences at P < 0.05 were considered to be statistically significant.
Results
Meta-analysis of publicly available microarray dataset
Dataset evaluation resulted in 13 included GSE datasets (Table 1) , comprising 221 normal control tissue and 477 
cancer tissue samples. From meta-analysis, 1385 and 1101 genes were found to be upregulated and downregulated, respectively. Nineteen differentially expressed genes were obtained from meta-analysis. Furthermore, 2839 genes were found to be differentially expressed in individual dataset but not in meta-analysis ( Fig. 1 ). Top 30 upregulated and downregulated genes identified by meta-analysis are shown in Table 3 and 4.
Bioinformatic analysis of the dysregulated genes
GO analysis revealed that the dysregulated genes were mostly involved in metabolic process and protein binding based on biological and molecular function category (Fig.  2 ). GO analysis of the cellular component determined that dysregulated genes were involved in nucleus and membrane. The directed acyclic graph demonstrated the enrichment of genes associated with various biological functions, including metabolic process, cell proliferation, wound healing, cell migration, locomotion and immune system (data not shown). KEGG pathway enrichment analysis categorized the dysregulated genes into various clusters. The majority of upregulated genes were involved in clusters as follow; pathways in cancer, small cell lung cancer, extracellular matrix (ECM)-receptor interaction, focal adhesion, and cell cycle. The majority of upregulated genes were clustered in the metabolic pathway, pathways in cancer, focal adhesion, cytokine-cytokine receptor interaction, cell cycle progression, and various signaling pathways, including MAPK, chemokine, JAK-STAT, neurotrophin, Wnt, p53, T-cell receptor, ErbB, NOD-like receptor, TGF-β, RIG-I-like receptor, B-cell receptor, VEGF, Fc epsilon RI, mTOR, Hedgehog, and Notch signaling pathway ( Fig. 3) . However, the majority of downregu-lated genes were clustered in metabolic pathway.
Notch signaling dysregulation in OSCC
Using KEGG analysis, 10 upregulated genes were categorized as Notch signaling pathway ( Table 5) . These genes were categorized as Notch ligand (JAG1 and JAG2), receptor proteolysis (ADAM17, NCSTN and PSEN1), transcriptional corepressor (NCOR2), and negative regulator (NUMB and DVL3). HDAC1 and HDAC2 were demonstrated to be involved in Notch signaling inhibition.
A γ-secretase inhibition resulted in the decrease of OSCC proliferation HSC-5 and HSC-4 were supplemented with different concentrations of γ-secretase inhibitor, DAPT. At concentrations ranging from 1 to 50 μM, DAPT was not toxic to both cell lines because there was no difference in the cell viability at day 1 (Fig. 4 ). Furthermore, it was observed that DAPT could inhibit HSC-5 and HSC-4 (50 μM) . It demonstrated that DAPT signifi cantly decreased HES1 expression in both HSC-5 and HSC-4 ( Fig. 5 ). HEY1 expression also decreased after DAPT treatment in HSC-5 but not in HSC-4. Corresponding with cell proliferation assay, DAPT treatment significantly inhibited C-FOS mRNA expression at 24 and 48   751  659  563  542  400  429  332  365  161  129  156  97  76  74   624  467  167  188  192  132  110  115  79  78  60  24  18  14  31  9  8  2  92   367  529  255  280  230  148  135  108  86  110  94  168  78  27  108  44  52  47  10  3  21  1  87   972   966  842  676  602   597  539  487  268  263  262  247  117  73   893  526  296  281  263  193  134  106  94  63  59  44  23  20  11  7  3  1  102   633  612  463  447  330  187  179  142  135  131  129  120  116  115  89  77  60  58  9  8  7  4  86   1000  800  600  400  200  0  200  400  600  800  1000 h in both cell lines (Fig. 5C, F) . These results imply that Notch signaling inhibition decreased cell proliferation in human OSCC cell lines, including HSC-5 and HSC-4.
A γ-secretase inhibition did not significantly influence OSCC cell migration
Baseline expression of HES1 and HEY1 was significantly higher in HSC-4, a metastatic phenotype cell line, than in HSC-5, a primary tumor phenotype cell line; this implied A B Fig. 3 The enriched KEGG pathways of the upregulated genes (B) and downregulated genes (A) in oral squamous cell carcinoma identified using WebGestalt. the correlation of Notch signaling in OSCC phenotype (Fig. 6 ).
To further demonstrate the role of Notch signaling in OSCC, cell migration was evaluated using in vitro wound healing assay. HSC-5 and HSC-4 monolayer were scratched and treated with DAPT (50 μM). At 24 h, HSC-5 cells migrated and completely filled the gap, but in the presence of DAPT, the space between the edges of the scratched line was still observed (Fig. 7) . In HSC-4, the space was still present in both control and DAPTtreated condition. Although cell migration was delayed in DAPT treated group, no statistical difference was noted ( Fig. 7 ).
Discussion
Microarray investigation of the differential gene expression between human OSCC and normal oral tissues has been discussed in previous studies (39, 40) . However, different results were obtained in these studies. This could be because of several reasons, including the different types of tissues sampled, sample number, platform of gene expression array, and data processing.
Thus, combining the observations of independent studies using meta-analysis method would generate new information to understand the differential gene expression and regulation of human OSCC. The present study performed meta-analysis of 13 microarray datasets with different platform and experimental design. This study compared gene expression of OSCC samples with normal tissue samples. Thus, the OSCC samples were included, regardless of their TMN stage, race, location, HPV status, habits, and other clinical parameters. Therefore, it should be noted that these parameters might influence the differential gene expression in OSCC. Further investigation of differential gene expression between different cancer stages, race, location, habits, and HPV status is indeed necessary to identify specific regulation mechanism(s).
A few studies were published regarding the metaanalysis of gene expression microarray experiments, comparing human OSCC and normal tissues (39, 40) . de Cecco et al. used a meta-analysis to identify molecular signature based on gene expression, which could be used as a prognostic factor (40) . Liu et al. performed a metaanalysis of 4 datasets and reported the altered regulation of genes associated with several pathways, including ECM receptor, cell cycle, cell communication, proteasome, bile acid synthesis, focal adhesion, glycerolopid metabolism, and arginine and proline metabolism in human OSCC (39) . Similar to the present study, pathways involved in ECM-receptor interaction, focal adhesion, and cell cycle progression were dysregulated and were ranked in the top 5 dysregulation pathways. However, the present study evaluated a related pathway for upregulated and downregulated genes. These results indicated that metabolic pathway had the highest number of dysregulated genes; however, a high number of upregulated genes were still involved in focal adhesion, cell cycle progression, and ECM-receptor interaction.
Based on KEGG pathway analysis, the present study identified that Notch signaling related genes were upregulated. JAG1 and JAG2 upregulation was identified by the meta-analysis. Correspondingly, previous work demonstrated that JAG1 and JAG2 mRNA levels were higher in OSCC cell line and tissue samples than in the adjacent non-neoplastic tissues (41) . Other studies also demonstrated the upregulation of JAG1 and other Notch signaling related genes in OSCC cell line and tissue samples (13) and that the attenuation of JAG1 expression resulted in the decrease of OSCC cell proliferation in vitro and tumor growth in vivo (13, 42) .
ADAM17 is a membrane-associated enzyme that cleaves various membrane proteins, including CD44, EGFR, and Notch receptors (43) (44) (45) . In human OSCC cell line, overexpression of ADAM17 exhibited higher cell viability, adhesion, and migration in vitro (46) . The increase in tumor size and cell proliferation was also noted in mice transplanted with ADAM17-overexpressing cells (46) . Correspondingly, suppression of ADAM17 expression in head and neck squamous cell carcinoma resulted in decreased tumorigenesis in vivo (44) .
HDACs are involved in oral cancer formation and progression (47) . Overexpression of HDAC1 (and not HDAC2) in tongue squamous cell carcinoma is associated with poor differentiation of stages and lymph node metastasis (47) . The siRNA targeting HDAC1 in OSCC cell line led to a decrease in cell proliferation and an increase in cell apoptosis (48) . It has been shown that HDAC inhibitor could inhibit hepatocellular carcinoma cell proliferation by attenuating NOTCH1 and HES1 expression (49) . However, the role of HDAC in Notch signaling in OSCC remains unclear.
NUMB attenuates Notch signaling activity. The present study demonstrated an upregulation of NUMB expression in OSCC samples. However, previous work reported that NUMB-1 mRNA was downregulated in esophageal squamous cell carcinoma compared to that in control tissues (50) . NUMB overexpression in human OSCC cell line and esophageal squamous cell carcinoma led to a decrease in cell proliferation, migration, and invasion (50, 51) . On the contrary, siNUMB treated cells exhibited higher cell growth and invasion in vitro (51) . In vivo orthotropic tumor formation assay did not show any difference in tumor formation between shNUMB cells and the control (51) .
Information regarding the influence of NCOR2, PSEN1, NCSTN, and DVL3 in OSCC is still limited. NCOR2 is a Notch signaling co-repressor. NCOR2 expression in breast cancer patients is associated with poor survival and shorter disease free interval (52) . NCSTN and PSEN1 are components of a γ-secretase complex that cleave the Notch receptor (53) . DVL3 is mainly involved in Wnt signaling. However, it has been shown that NICD binds to DVL, leading to both Notch and Wnt signaling inhibition (54) . The role of these genes in human OSCC should be further examined.
It should be noted that the upregulated genes related to Notch signaling in OSCC samples are involved in both positive and negative regulation of Notch signaling. Dysregulation of these genes and other Notch related genes should be further confirmed. In addition, further investigation is required to determine the influence of Notch signaling on OSCC behavior.
Furthermore, we performed in vitro experiments to determine the role of Notch signaling in OSCC cell proliferation and migration. The results showed that Notch signaling inhibition resulted in the decrease of OSCC cell proliferation. Correspondingly, previous studies demonstrated that DAPT treatment inhibited cell proliferation in various cancer cell types, including hepatocellular carcinoma, glioma, lung adenocarcinoma, and OSCC (55) (56) (57) (58) . Several mechanisms have been examined, including apoptosis induction, cell cycle arrest, and cancer cell cytotoxicity. In the present study, the marked reduction of proliferative marker, C-FOS was decreased upon DAPT treatment, implying the potential regulation mechanism in these OSCC cell lines.
Notch signaling inhibition resulted in the attenuation of cancer cell invasion and migration (55, 56, 59) . In this regard, DAPT significantly inhibited breast cancer cell migration in an in vitro wound healing assay. Furthermore, DAPT could inhibit hepatocellular carcinoma cell invasion in matrigel-coated transwell assay (55) . Although, the attenuation of DAPT on OSCC cell migration was noted in the present study, no statistical significance was observed. Several factors could be responsible for this discrepancy. First, different model and cell types for cell migration and invasion play a crucial role. Cell invasion through matrigel requires a different mechanism compared to those with cell migration in wound healing assay. Furthermore, some studies supplement chemotactic factor in culture medium to enhance cell invasion and migration ability. It has been illustrated that Notch signaling regulated ovarian cancer cell migration by increasing SDF1 expression (5) .
The expression of intrinsic Notch target genes (HES1, HES5, and HEY1) increased with the invasive ability of hepatocellular carcinoma cell line (55) . Consistently, HSC-4 exhibited higher HES1 and HEY1 expression than HSC-5. The HSC-4 cell line was obtained from a metas-tasis lymph node of OSCC, whereas HSC-5 was derived from primary site of OSCC. Hence, these results imply the relationship of Notch signaling in the invasiveness of OSCC. However, further investigations are indeed necessitated to confirm this statement.
